Haines, RA, Urbiztondo, RA, Haynes, RA, Simpson, E, Niewiesk, S, Lairmore, MD
Characterization of New Zealand White Rabbit Gut-Associated Lymphoid Tissues and Use as Viral Oncology Animal Model.
Lairmore, MD, Niewiesk, S
Models of Virus-Induced Carcinogenesis and Oncolytic Viruses.
Lairmore, MD, Ilkiw, J
Animals Used in Research and Education, 1966-2016: Evolving Attitudes, Policies, and Relationships.
Romeo, MM, Ko, B, Kim, J, Brady, R, Heatley, HC, He, J, Harrod, CK, Barnett, B, Ratner, L, Lairmore, MD, Martinez, E, Lüscher, B, Robson, CN, Henriksson, M, Harrod, R
Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.
Lairmore, MD, Khanna, C
Naturally occurring diseases in animals: contributions to translational medicine.
Parrula C, Fernandez SA, Landes K, Huey D, Lairmore M, Niewiesk S
Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness.
Dodon MD, Villaudy J, Gazzolo L, Haines R, Lairmore M
What we are learning on HTLV-1 pathogenesis from animal models.
Lairmore M, Haines R, Anupam R
Mechanisms of human T-lymphotropic virus type 1 transmission and disease.
Doueiri R, Anupam R, Kvaratskhelia M, Green KB, Lairmore M, Green PL
Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.